J1553Drugs Administered Other than Oral Method

Injection, immune globulin (yimmugo), 100 mg

Short description: Inj yimmugo 100 mg

Effective date: April 1, 2026
Termination date: —

Related codes (J-series)

J0013Esketamine, nasal spray J0014Cocaine hcl nasal (goprelto)J0120Tetracyclin injection J0121Inj., omadacycline, 1 mg J0122Inj., eravacycline, 1 mg J0129Abatacept injection J0130Abciximab injection J0131Inj, acetaminophen (nos)J0132Acetylcysteine injection J0133Acyclovir injection J0134Inj acetaminophen -fresenius J0135Adalimumab injection

Frequently asked questions

What is HCPCS code J1553?

J1553 is a HCPCS Level II code for Injection, immune globulin (yimmugo), 100 mg.

What category is HCPCS code J1553 in?

J1553 falls under the Drugs Administered Other than Oral Method category of HCPCS Level II.

When did HCPCS code J1553 become effective?

J1553 has been effective since April 1, 2026, per CMS's quarterly HCPCS update.

HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.